This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Schering Corporation. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Rong Kong - Innovator in Viral Entry Inhibition
Introduction
Rong Kong is a notable inventor based in Scotch Plains, NJ (US). He has made significant contributions to the field of virology, particularly in developing methods to combat viral infections. His work focuses on innovative solutions to treat and prevent diseases caused by the Flaviviridae virus, including hepatitis C.
Latest Patents
Rong Kong holds a patent for peptide viral entry inhibitors. This invention provides peptide compositions and methods aimed at treating and preventing infections caused by the Flaviviridae virus. His innovative approach has the potential to impact the medical field significantly.
Career Highlights
Rong Kong is associated with Schering Corporation, where he applies his expertise in virology and peptide research. His work at the company has allowed him to contribute to advancements in therapeutic solutions for viral infections.
Collaborations
Rong Kong has collaborated with notable colleagues, including Rong Liu and Rumin Zhang. These partnerships have fostered a collaborative environment that enhances research and innovation in their field.
Conclusion
Rong Kong's contributions to the development of peptide viral entry inhibitors highlight his role as an innovator in the fight against viral infections. His work continues to pave the way for new therapeutic strategies in virology.